Business
EU Marketing Submission
EU Marketing Submission.
About this update from Futura Medical Plc
[{"type":"text","content":"\n Futura Medical PLC\n28 November 2005\n\n\nFor immediate release 28 November 2005\n\n\n Futura Medical plc\n Announces the submission of CSD500 device dossier\n for EU marketing author isation\n\nFutura Medical plc (AIM: FUM), the pharmaceutical drug and medical device group\nthat develops innovative products for the sexual healthcare market, announces\nsubmission of the regulatory dossier for the condom safety device CSD500. This\ndossier has been submitted to the relevant Notified Body/Competent Authority for\nseeking market authorisation in the European Union.\n\nCSD500 will be marketed as a Durex(TM) branded condom containing an active\ncompound which will enhance the barrier function of the condom. The active\ncompound will help healthy men to maintain a fuller and firmer erection during\nsexual intercourse, thereby helping to reduce the risk of condom slippage.\n\nDurex(TM) has a 29% share of the global market for branded condoms with sales of\n£146 million in 2004. Seventy nine percent (79%) of SSL group sales in 2004 were\nin Europe where the initial marketing authorisations will be sought for CSD500.\nAlthough the precise terms of the deal are confidential, Futura will receive\nroyalty based payments from sales of the CSD500 condom.\n\nJames Barder, Chief Executive of Futura, said: 'We are delighted to reach this\nmajor milestone for the first of our three leading products which will reinforce\nour position as an innovative sexual health company. The dossier submission\ndemonstrates Futura's ability to work closely with our commercial partners to\novercome technical challenges and to drive investor value. Consumers' sexual\nhealth is a key issue for medical authorities with the increase in Sexually\nTransmitted Infections such as chlamydia. In this context, combined with the\nevolving market for sexual health products and working with Durex(TM) as the\nleading global condom brand, we believe CSD500 will generate significant \ndemand.'\n\nChris Bunniss, SSL's group marketing and innovations director, said: 'Durex(TM) is\nno longer a brand associated purely with safer sex, but better sex too. We are\nconstantly looking at the development of innovative products in the area of\nsexual enhancement. We believe CSD500 could become an exciting addition and\nleading product within the Durex(TM) range that will help to improve...